Katarzyna Behrendt
Overview
Explore the profile of Katarzyna Behrendt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
138
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Walaszczyk A, Pietrowska M, Wojakowska A, Abramowicz A, Chmura A, Maslyk B, et al.
Protein Pept Lett
. 2018 Jan;
24(1):37-45.
PMID: 29366405
Adjuvant chemo- and/or radiotherapy is applied in a majority of patients treated for early stage breast cancer, although only a small percentage of these individuals are at high risk of...
2.
Idasiak A, Galwas-Kliber K, Behrendt K, Wzietek I, Kryj M, Stobiecka E, et al.
Br J Radiol
. 2017 May;
90(1074):20160731.
PMID: 28466686
Objective: The study was prospectively designed as a single-arm, single-institution prospective trial of pre-operative concomitant hyperfractionated radiotherapy (HART) with co-administration of chemotherapy based on 5-fluorouracil (5FU) in patients with T2/N+...
3.
Gawkowska-Suwinska M, Fijalkowski M, Bialas B, Szlag M, Kellas-Sleczka S, Nowicka E, et al.
J Contemp Brachytherapy
. 2017 Jan;
1(4):211-215.
PMID: 28050174
Purpose: The aim of the study was to analyze early effects and toxicity of salvage high dose rate brachytherapy for local recurrences of adenocarcinoma of the prostate after external beam...
4.
Boonstra P, Taylor J, Smolska-Ciszewska B, Behrendt K, Dworzecki T, Gawkowska-Suwinska M, et al.
Br J Radiol
. 2016 Feb;
89(1061):20150957.
PMID: 26903392
Objective: There is disagreement regarding the value of the α/β ratio for prostate cancer. Androgen deprivation therapy (ADT) may dominate the effects of dose fractionation on prostate-specific antigen (PSA) response...
5.
Smolska-Ciszewska B, Miszczyk L, Bialas B, Fijalkowski M, Plewicki G, Gawkowska-Suwinska M, et al.
Radiat Oncol
. 2015 Apr;
10:60.
PMID: 25884489
Background: Clinical data that compare external-beam radiotherapy (EBRT) combined with high-dose-rate brachytherapy (HDR-BT) boost versus EBRT alone are scarce. The analysis of published studies suggest that biochemical relapse-free survival in...
6.
Gawkowska-Suwinska M, Blamek S, Heyda A, Boguszewicz L, Cichon A, Zarudzki L, et al.
Rep Pract Oncol Radiother
. 2014 Oct;
19(6):361-8.
PMID: 25337408
Aim: To evaluate the tolerability and toxicity of PCI in patients with NSCLC. Background: Prophylactic cranial irradiation (PCI) is a standard treatment for patients with small cell lung cancer. There...
7.
Behrendt K, Nowicka E, Gawkowska-Suwinska M, Plewicki G, Smolska-Ciszewska B, Giglok M, et al.
Rep Pract Oncol Radiother
. 2014 Sep;
19(5):337-42.
PMID: 25184059
Aim: To assess acute and late toxicity of hypofractionated radiotherapy, its efficacy and impact on quality of life in patients with low-risk prostate cancer. Materials And Methods: Since August 2006...
8.
Mauguen A, Le Pechoux C, Saunders M, Schild S, Turrisi A, Baumann M, et al.
J Clin Oncol
. 2012 Jul;
30(22):2788-97.
PMID: 22753901
Purpose: In lung cancer, randomized trials assessing hyperfractionated or accelerated radiotherapy seem to yield conflicting results regarding the effects on overall (OS) or progression-free survival (PFS). The Meta-Analysis of Radiotherapy...
9.
Pietrowska M, Polanska J, Marczak L, Behrendt K, Nowicka E, Stobiecki M, et al.
J Transl Med
. 2010 Jul;
8:66.
PMID: 20618994
Background: The proteomics approach termed proteome pattern analysis has been shown previously to have potential in the detection and classification of breast cancer. Here we aimed to identify changes in...
10.
Pietrowska M, Marczak L, Polanska J, Behrendt K, Nowicka E, Walaszczyk A, et al.
J Transl Med
. 2009 Jul;
7:60.
PMID: 19594898
Background: Mass spectrometric analysis of the blood proteome is an emerging method of clinical proteomics. The approach exploiting multi-protein/peptide sets (fingerprints) detected by mass spectrometry that reflect overall features of...